Found 6 articles for: "cicatricial alopecia"

Patient Perspectives and Attitudes Toward the Diagnostic Process for Central Centrifugal Cicatricial Alopecia

March 2026 | Volume 25 | Issue 3 | Features | 282 | Copyright © March 2026

Read More

Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia: An Open-Label Pilot Study

September 2025 | Volume 24 | Issue 9 | Original Article | 891 | Copyright © September 2025

Alopecia as an Adverse Event of Immune Checkpoint Inhibitor Therapies: Clinical Evidence and Outcomes

March 2025 | Volume 24 | Issue 3 | Original Article | 255 | Copyright © March 2025

Utilization Management Barriers Among Patients With Cicatricial Alopecia

March 2023 | Volume 22 | Issue 3 | Features | 312 | Copyright © March 2023

Citation: Rypka K, Pathoulas J, Wharton K, et al. Utilization management barriers among patients with cicatricial alopecia. J Drugs Dermatol. 2023;22(3):312-314. doi:10.36849/JDD.684...
Read More

Examining the Potential for Koebnerization and Disease Precipitation in Cicatricial Alopecias

January 2023 | Volume 22 | Issue 1 | Original Article | 29 | Copyright © January 2023

The treatment of primary scarring alopecias is challenging and patients may be susceptible to koebnerization. This predisposes cicatricial alopecia patients to worsening of their disease following pro...
Read More

COVID-19 in Individuals Treated With Long-Term Hydroxychloroquine: A Propensity Score-Matched Analysis of Cicatricial Alopecia Patients

August 2021 | Volume 20 | Issue 8 | Editorials | 914 | Copyright © August 2021

Early in the COVID-19 pandemic, anti-malarial agent hydroxychloroquine (HCQ) was touted as a potentially effective COVID-19 treatment due to its purported antiinflammatory and antiviral effects....
Read More